Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Angewandte Chemie (International Ed. in English)
|
November 6, 2021
Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*
João P M António, Joana Inês Carvalho, Ana S André, et al.
Environmental Monitoring and Assessment
|
September 1, 2018
Metal loads and biomarker suite responses in a tropical carnivorous fish indicative of anthropogenic impacts in a Southeastern Brazilian lagoon
R S C Coimbra, M S Mascarenhas, V B Saraiva, et al.
Lupus
|
January 31, 2017
Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups
S R M Lopes, N W S Gormezano, R C Gomes, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Angewandte Chemie (International Ed. in English)
|
November 6, 2021
Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*
João P M António, Joana Inês Carvalho, Ana S André, et al.
Environmental Monitoring and Assessment
|
September 1, 2018
Metal loads and biomarker suite responses in a tropical carnivorous fish indicative of anthropogenic impacts in a Southeastern Brazilian lagoon
R S C Coimbra, M S Mascarenhas, V B Saraiva, et al.
Lupus
|
January 31, 2017
Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups
S R M Lopes, N W S Gormezano, R C Gomes, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Selective Inhibition of Bruton's Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B Sousa, Cátia Rebelo de Almeida, Ana F Barahona, et al.
Page
of 3